Unusual antimicrotubule activity of the antifungal agent spongistatin 1

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1993-1999

  Ovechkina, Yulia Y ^a   Pettit, Robin K ^b   Cichacz, Zbigniew A ^b   Pettit, George R ^b   Oakley, Berl R ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BENOMYL; SPONGISTATIN 1; UNCLASSIFIED DRUG;

ANAPHASE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIDULANS; CHROMOSOME; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; MICROTUBULE; MINIMUM INHIBITORY CONCENTRATION; MITOSIS INDEX; NONHUMAN; PRIORITY JOURNAL; SPONGE (PORIFERA); TELOPHASE;

EID: 0032839247     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1993     Document Type: Article

References (14)

1. Bai, R., Z. A. Cichacz, C. L. Herald, G. R. Pettit, and E. Hamel. 1993. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of Vinblastine to tubulin. Mol. Pharmacol. 44:757-766.
2. Bergen, L. G., and N. R. Morris. 1983. Kinetics of the nuclear division cycle of Aspergillus nidulans. J. Bacteriol. 156:155-160.
3. Cove, D. J. 1966. The induction and repression of nitrate reductase in the fungus Aspergillus nidulans. Biochim. Biophys. Acta 113:51-56.
4. Espinel-Ingrof, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, Jr., A. Fothergill, M. R. McGinnis, P. Menenzes, S. A. Messer, P. W. Nelson, T. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of a proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
5. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 633 Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
6. Jung, M. K., G. S. May, and B. R. Oakley. 1998. Mitosis in wild-type and β-tubulin mutant strains of Aspergillus nidulans. Fungal Genet. Biol. 24:146-160.
7. Martin, M. A., S. A. Osmani, and B. R. Oakley. 1997. The role of γ-tubulin in mitotic spindle formation and cell cycle progression in Aspergillus nidulans. J. Cell Sci. 110:623-633.
8. Oakley, B. R., and N. R. Morris. 1981. A β-tubulin mutation in Aspergillus nidulans that blocks microtubule function without blocking assembly. Cell 24:837-845.
9. Ovechkina, Y. Y., and B. R. Oakley. Unpublished data.
10. Pettit, G. R., Z. A. Cichacz, C. L. Herald, M. R. Boyd, J. M. Schmidt, and J. N. A. Hooper. 1993. Isolation and structure of spongistatin 1. J. Org. Chem. 58:1302-1304.
11. Pettit, R. K., S. C. McAllister, G. R. Pettit, C. L. Herald, J. M. Johnson, and Z. A. Cichacz. 1998. A broad-spectrum antifungal from the marine sponge Hyrtios erecta. Int. J. Antimicrob. Agents 9:147-152.
12. Roncal, T., U. O. Ugalde, J. Barnes, and D. Pitt 1991. Production of protoplasts of Penicillium cyclopium with improved viability and functional properties. J. Gen. Microbiol. 137:1647-1651.
13. Van Tuyl, J. M. 1977. Genetics of fungal resistance to systemic fungicides. Meded. Landbouwhogesch. Wageningen 2:1-137.
14. Wilson, L., and M. A. Jordan. 1994. Pharmacological probes of microtubule function, p. 59-83. In J. S. Hyams and C. W. Lloyd (ed.), Microtubules. Wiley-Liss, New York, N.Y.